Ervant J Maksabedian Hernandez

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Interstitial Lung Disease

Rheumatoid Arthritis

Top Venues

Journal of medical economics

ACR open rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Philip S Helliwell, Yomei Shaw, Michele Almonte, Ervant J Maksabedian Hernandez, Bradley Stolshek, Kaleb Michaud
Perspectives on Treatment Burden for Methotrexate and Tumor Necrosis Factor Inhibitors Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis: A Qualitative Study. ACR open rheumatology (2023)
Ervant J Maksabedian Hernandez, Marlon Graf, Alexandria Portelli, Jason Shafrin
Estimating the impact of biosimilar entry on prices and expenditures in rheumatoid arthritis: a case study of targeted immune modulators. Journal of medical economics 25 (1) (2022)
Alexis Ogdie, Ervant J Maksabedian Hernandez, Yomei Shaw, Bradley Stolshek, Kaleb Michaud
Side Effects of Methotrexate and Tumor Necrosis Factor Inhibitors: Differences in Tolerability Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis. ACR open rheumatology 4 (11) (2022)
Vibeke Strand, Phillip J Mease, Ervant J Maksabedian Hernandez, Bradley S Stolshek, Lyrica X H Liu, David H Collier, Gregory Kricorian, Joseph F Merola
Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combination. RMD open 7 (1) (2021)
Ervant J Maksabedian Hernandez, Isabelle Tingzon, Lorenzo Ampil, Jessica Tiu
Identifying chronic disease patients using predictive algorithms in pharmacy administrative claims: an application in rheumatoid arthritis. Journal of medical economics 24 (1) (2021)